These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 826183)

  • 1. Chemical, biological, and immunological characterization of mono- and diiodothyrotropin releasing factor.
    Ling N; Leppäluoto J; Vale W
    Anal Biochem; 1976 Nov; 76(l):125-33. PubMed ID: 826183
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of specific antiserum to thyrotropin releasing-hormone and its use in a radioimmunoassay.
    Koch Y; Baram T; Fridkin M
    FEBS Lett; 1976 Apr; 63(2):295-8. PubMed ID: 816673
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of bioreactivity and preservation of immunoreactivity of iodothyrotropin-releasing hormone.
    Martino E; Seo H; Refetoff S
    Endocrinology; 1978 Jul; 103(1):246-53. PubMed ID: 105887
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma.
    Eskay RL; Oliver C; Warberg J; Porter JC
    Endocrinology; 1976 Feb; 98(2):269-77. PubMed ID: 813988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity and serum destruction of N3immethyl-trh.
    Dvorak JC; Utiger RD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):582-5. PubMed ID: 402384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new radioimmunoassay of thyrotropin-releasing hormone.
    Visser TJ; Klootwijk W; Docter R; Hennemann G
    FEBS Lett; 1977 Nov; 83(1):37-40. PubMed ID: 411687
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyrotropin and prolactin inhibitory studies by compounds related to the thyrotropin releasing hormone.
    Sievertsson H; Castensson S; Andersson K; Björkman S; Bowers CY
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1401-7. PubMed ID: 811221
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of pyroglutamyl-histidyl-thiazolidine-4-carboxamide, a biologically active analog of the thyrotropin releasing factor.
    Willson CG; Gilon C; Donzel B; Goodman M
    Biopolymers; 1976 Nov; 15(11):2317-22. PubMed ID: 825153
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibitory action of analogs of thyrotropin-releasing hormone on the release of thyrotropin in vitro.
    Castensson S; Björkman S; Sievertsson H
    Acta Pharm Suec; 1977; 14(5-6):505-16. PubMed ID: 413330
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformational analysis of NMR of an analogue of thyrotropin releasing factor: the tripeptide is less than Glu-Leu-Pro-A.
    Bellocq AM; Dubien M; Dupart E
    Biochem Biophys Res Commun; 1975 Aug; 65(4):1393-9. PubMed ID: 829894
    [No Abstract]   [Full Text] [Related]  

  • 11. IMMUNOLOGIC STUDIES OF PURIFIED HUMAN AND BOVINE THYROTROPIN.
    UTIGER RD; ODELL WD; CONDLIFFE PG
    Endocrinology; 1963 Sep; 73():359-65. PubMed ID: 14065115
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo stimulation of prolactin secretion in the rat by thyrotropin releasing factor, related peptides and hypothalamic extracts.
    Rivier C; Vale W
    Endocrinology; 1974 Oct; 95(4):978-83. PubMed ID: 4213178
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton nuclear magnetic resonance studies of Nepsilon-Me-His2-thyroliberin. An hyperactive analogue of thyroliberin (thyrotropin-releasing factor).
    Bellocq AM; Dubien M
    Biochim Biophys Acta; 1976 Jan; 420(1):1-7. PubMed ID: 813772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trial immunological study of thyrotropin and the exophthalmogenic factor].
    HENNEN G; WINAND R
    Rev Fr Etud Clin Biol; 1963 May; 8():476-80. PubMed ID: 13953762
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and characterization of a high-affinity photoactivatable analogue of thyrotropin-releasing hormone.
    Brady KD; Tashjian AH
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):179-84. PubMed ID: 1310004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ability of thyrotropin-releasing hormone and N3im-methyl-thyrotropin-releasing hormone to affect prolactin and thyrotropin production in primary rat pituitary cell cultures.
    Dannies PS; Markell MS
    Endocrinology; 1980 Jan; 106(1):107-12. PubMed ID: 6765928
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor.
    Burgus R; Dunn TF; Desiderio D; Ward DN; Vale W; Guillemin R
    Nature; 1970 Apr; 226(5243):321-5. PubMed ID: 4985794
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic immunization of endogenous thyrotrophin-releasing hormone (TRH) in brain alters the behavioural response to pentobarbital and a TRH analogue.
    Lighton C; Bennett GW; Marsden CA
    Brain Res; 1986 Jul; 378(2):385-9. PubMed ID: 3089541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.
    Vonhof S; Feuerstein GZ; Cohen LA; Labroo VM
    Eur J Pharmacol; 1990 May; 180(1):1-12. PubMed ID: 2163861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of an analogue of thyroliberin (T.R.F.).
    Bellocq AM; Castensson S; Sievertsson H
    Biochem Biophys Res Commun; 1977 Jan; 74(2):577-83. PubMed ID: 402135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.